3BP is commercializing three aspects of its technology platform:
- Out-licensing of therapeutic and diagnostic product candidates after preclinical or clinical proof-of concept
- Running collaborative peptidomimetics drug discovery programs from hit to preclinical candidate together with pharmaceutical partners
- Custom development of affinity purification steps based on 3BP's peptidomimetic affinity ligand (PurAffinTM) technology for protein downstream processing
Experts in peptide drug discovery. Ingenuity from concept to clinical candidate.